Treatment with Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma

Tejas P. Joshi; Madeleine Duvic; Carlos A. Torres-Cabala; Jaime Tschen

doi:10.1001/jamadermatol.2022.0613

Treatment with Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma

Tejas P. Joshi, Madeleine Duvic, Carlos A. Torres-Cabala, Jaime Tschen

Pathology, Anatomical

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	697-699
Number of pages	3
Journal	JAMA Dermatology
Volume	158
Issue number	6
DOIs	https://doi.org/10.1001/jamadermatol.2022.0613
State	Published - Jun 2022

ASJC Scopus subject areas

Dermatology

Access to Document

10.1001/jamadermatol.2022.0613

Cite this

@article{45a83026095c4419a838c2ed532f7dcf,

title = "Treatment with Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma",

author = "Joshi, {Tejas P.} and Madeleine Duvic and Torres-Cabala, {Carlos A.} and Jaime Tschen",

year = "2022",

month = jun,

doi = "10.1001/jamadermatol.2022.0613",

language = "English (US)",

volume = "158",

pages = "697--699",

journal = "JAMA Dermatology",

issn = "2168-6068",

publisher = "American Medical Association",

number = "6",

}

TY - JOUR

T1 - Treatment with Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma

AU - Joshi, Tejas P.

AU - Duvic, Madeleine

AU - Torres-Cabala, Carlos A.

AU - Tschen, Jaime

PY - 2022/6

Y1 - 2022/6

UR - http://www.scopus.com/inward/record.url?scp=85128720501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85128720501&partnerID=8YFLogxK

U2 - 10.1001/jamadermatol.2022.0613

DO - 10.1001/jamadermatol.2022.0613

M3 - Letter

C2 - 35416914

AN - SCOPUS:85128720501

SN - 2168-6068

VL - 158

SP - 697

EP - 699

JO - JAMA Dermatology

JF - JAMA Dermatology

IS - 6

ER -

Treatment with Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this